Nuvation Bio logo

Nuvation Bio

BrandNew York, New YorkWebsite

Company Overview

Nuvation Bio is a global biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel therapeutic candidates. Nuvation Bio’s portfolio includes taletrectinib (ROS1), safusidenib (mIDH1), NUV-868 (BET), and NUV-1511 (DDC). Nuvation Bio was founded in 2018 by biopharma industry veteran David Hung, M.D., who previously founded Medivation, Inc., which brought to patients one of the world’s leading prostate cancer medicines. Nuvation Bio has offices in New York, San Francisco, and Shanghai.
Founded
2018
Headquarters
New York, New York
Employees
51-200
46.7% growth last 12mo
Marketing Team
17
8% of company

Overall Headcount Trend

Overall Headcount Trend

Company growth over the last 12 months

Salaries

Community Salary Data

Help build salary transparency at Nuvation Bio. Share your compensation anonymously.

Contribute

Reviews

Jobs